This is an example showing how PERT administration data may be represented.
cm.xpt
Row 1:
Shows that subject 1200 took 2500 lipase units/kg of pancrelipase with a meal. This treatment started before the sponsor-defined study reference period and ended (as shown in CMENDTC).
Row 2:
Shows the subject took 1000 lipase units/kg of pancrelipase with a snack. This treatment started before and ended after the sponsor-defined study reference period.
Row 3:
Shows the dose was increased to 3000 lipase units/kgof pancrelipase with a meal. This new dose was started as shown in CMSTDTC.
Row 4:
Shows data for subject 1202 using the number of capsules, rather than dosage. The strength of each capsule is represented in CMPSTRG and CMPSTRGU.
Row 5:
Shows that subject 1203 took a total of 30,000 lipase units per meal. The treatment ended after the study.